ICD-10 Coding for Tetrahydrocortisol Use(E25.0, E25.9U, E27.40)
Learn about the ICD-10 coding and documentation requirements for tetrahydrocortisol use, including primary and ancillary codes, clinical validation, and billing considerations.
Complete code families applicable to Tetrahydrocortisol Use
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E27.40 | Adrenocortical insufficiency, unspecified | Use when adrenal insufficiency is suspected based on clinical symptoms and lab findings. |
|
| R94.6 | Abnormal cortisol levels | Use when lab results indicate abnormal cortisol levels without a confirmed adrenal disorder. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutTetrahydrocortisol Use
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Tetrahydrocortisol Use.
Vague documentation of cortisol levels.
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Use specific lab values and ratios., Ensure documentation includes test methods.
Using R94.6 without specifying adrenal etiology.
Impact
Reimbursement: May lead to claim denials due to lack of specificity., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Reduces accuracy of clinical data.
Mitigation
Add E27.40 and LOINC 82908-5 when ratios confirm adrenal dysfunction.
Specificity of adrenal disorder coding
Impact
Risk of audits due to non-specific coding of adrenal disorders.
Mitigation
Ensure documentation supports specific adrenal disorder codes.